Ashleigh Palmer, Director and CEO at Provention Bio, Inc. (PRVB), sold 101,670 shares at $10.11 ($1.0M) on 2023-02-10, disclosed to the SEC on 2023-02-14.
Open-market sale of $1.0M PRVB by Director and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.11 | 50,000 | $506K | 49.4% |
| 2 | $10.04 | 25,835 | $259K | 25.3% |
| 3 | $10.04 | 25,835 | $259K | 25.3% |
| Total | $10.07 avg | 101,670 | $1.0M | 100% |
| Filing → |
| PRVB | BUY | 2020-08-18 | $6K | — | Filing → |
| PRVB | BUY | 2020-08-17 | $36K | — | Filing → |
| PRVB | BUY | 2019-12-23 | $24K | — | Filing → |